Contineum Therapeutics CTNM Institutional Ownership

Updated Oct 11, 2026

Contineum Therapeutics, Inc. (NASDAQ:CTNM) was held by 103 institutional investors that filed 13F reports for the quarter ended June 30, 2026.

• These investors held 81.21% of outstanding shares in Q2 2026, down from 81.73% the quarter before.
• Total holdings of CTNM shares fell 0.03% from Q1 2026, and the holder count rose 53.73% from Q2 2025.
• Of the 103 holders of CTNM in Q2 2026, 62 added to their positions, 19 reduced their stakes and 22 left their positions unchanged.
• Altogether, institutional holders owned 30.55Mn CTNM shares at the end of Q2 2026, down 9.2K from the prior quarter and up 16.77Mn from a year earlier.
• Montanova Capital, LLC held the largest position in CTNM at 2.84Mn shares as of June 30, 2026, or 7.55% of shares outstanding.
• The biggest increases in CTNM positions during Q2 2026 came from BlackRock, Inc. (+1.4Mn shares), Geode Capital Management, LLC (+411.15K shares), State Street Corp (+324.62K shares), FMR LLC (+225.26K shares) and Northern Trust Corp (+211.88K shares).
• The biggest cuts to CTNM positions during Q2 2026 came from Millennium Management LLC (-603.74K shares), Susquehanna International Group, LLP (-296.08K shares), Balyasny Asset Management L.P. (-162.84K shares), Marshall Wace, LLP (-108.24K shares) and UBS Group AG (-99.77K shares).
• Business Quant data shows the 10 biggest positions in Contineum Therapeutics as of Q2 2026 were held by Montanova Capital, LLC (2.84Mn shares), Jupiter Topco LLC (2.73Mn shares), BlackRock, Inc. (2.06Mn shares), Johnson & Johnson (1.98Mn shares), Franklin Templeton Inc (1.84Mn shares), Balyasny Asset Management L.P. (1.52Mn shares), Vanguard Capital Management LLC (1.32Mn shares), Perceptive Advisors LLC (1.26Mn shares), FMR LLC (1.04Mn shares) and Millennium Management LLC (931.71K shares).